MENDLEIN JOHN 4
4 · FATE THERAPEUTICS INC · Filed Jan 13, 2023
Insider Transaction Report
Form 4
MENDLEIN JOHN
Director
Transactions
- Purchase
Common Stock
2023-01-13$5.43/sh+36,631$198,906→ 282,770 total - Purchase
Common Stock
2023-01-11$5.67/sh+88,048$499,232→ 246,139 total